D
Desupervised
The startup has developed an AI-driven drug discovery platform that utilizes machine learning algorithms to predict compound-protein binding probabilities. This technology reduces the incidence of false positives in drug screening, enabling pharmaceutical companies to accelerate the discovery process while minimizing costs and resource expenditure.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$630KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an AI-driven drug discovery platform that utilizes machine learning algorithms to predict compound-protein binding probabilities. This technology reduces the incidence of false positives in drug screening, enabling pharmaceutical companies to accelerate the discovery process while minimizing costs and resource expenditure.